New Phase of one of the NVU’s priority research projects: Enhancement of Oncological Patient’s Quality of Life through Intraoperative Radiotherapy has been approved. It aims to assess changes in health-related quality of life (HRQOL) in oncological patients as an outcome of intraoperative radiotherapy considering relationship with age, cancer stage and presence of any comorbidity.

The Project Team Leader is Prof. Dr. med. Mikhail Janjalia; International Partner: Carl Zeiss Meditec AG; the NVU share in project implementation so far amounts to GEL 1,820 Mln.